How Can Transparency Improve in RWD Studies?

June 29, 2021

Vice President and Global Head of Epidemiology for Johnson & Johnson Jesse Berlin shared his thoughts on real world evidence (RWE) and real world data (RWD). He notes several challenges that must be considered and overcome to effectively use RWD.

“Jesse Berlin, Vice President and Global Head of Epidemiology for Johnson & Johnson (PA, USA), discusses challenges associated with working with real-world and epidemiologic data, as well as how we may help advance transparency in the context of studies utilizing these.” Read more here.

(Source: Jesse Berlin, The Evidence Base, 5/27/21)

Share This Story!